New from NICE

Pembrolizumab for advanced melanoma not previously treated with ipilimumab. Pembrolizumab (Keytruda) is a humanised monoclonal antibody. It acts on the programmed cell death protein-1 immune-checkpoint receptor pathway, blocking its interaction with ligand on the tumour cells.

New from NICE

Add yours ↓
Web design and marketing agency Leamington Spa